Myosin-9 (MYH9 or DFNA17) Antibody - FFPE Validated

Protein Function

This antibody is suited for researchers who want to examine Myosin-9 and relate it to cell-state biology. Myosin-9 is a structural protein that interfaces with actin, microtubules, or associated adaptors. Its behavior can reflect changes in differentiation state, stress, or remodeling of cellular architecture.

Tracking Myosin-9 can clarify whether changes reflect regulation, redistribution, or altered complex assembly.

Experimental Applications

Drug perturbations that affect polymerization or contractility can shift distribution and complex formation. Because regulation can be multi-layered, combining abundance and localization information can sharpen conclusions.

Many workflows benefit from tracking both signal intensity and compartment distribution, especially when the target participates in multi-protein assemblies. Kidney disease modeling efforts may include this target when exploring podocyte stress responses and structural change.

Common experimental questions that benefit from target tracking include:

• differences across cell density or substrate stiffness
• association with junctional complexes or focal adhesions
• stress-fiber versus cortical distribution patterns

Workflow Perspective

In sectioned tissue workflows, interpretation often depends on morphology; this format supports that style of readout. To keep comparisons consistent, align sample preparation steps and define a clear baseline for each series.

For challenging targets, pairing Myosin-9 measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

The fixed-section version supports deeper biological narratives around Myosin-9 without overcomplicating setup.